The nurse is preparing the client for discharge. Provider Prescriptions:
Ethambutol 1,200 mg PO daily Rifampin 600 mg PO daily Isoniazid 300 mg PO daily Pyrazinamide 1,600 mg PO daily
Acetaminophen 650 mg PO three times daily every 6 hr PRN for fever greater than 38°C (100.4°F).
Discharge prescriptions, 0800:
Ethambutol 1,200 mg PO daily Rifampin 600 mg PO daily Isoniazid 300 mg PO daily Pyrazinamide 1,600 mg PO daily
Which of the following statements indicates the client understands the discharge teaching?
Select the 3 client statements that indicate an understanding of the teaching.
A.
“I can expect my contact lenses to turn red or orange.”
B.
“I will need to have a repeat Mantoux test in 4 weeks.”
C.
“I should notify my provider if I start taking new over-the-counter or prescription medications.”
D.
“I am no longer contagious.”
E.
“I will need to take my medications for a total of 6 weeks.”
F.
“I will need to have someone observe me when I take my medication.”
G.
“I can continue my current alcohol intake.”
The Correct answer and Explanation is:
The three statements that indicate the client understands the discharge teaching regarding their tuberculosis (TB) treatment are:
C. “I should notify my provider if I start taking new over-the-counter or prescription medications.”
D. “I am no longer contagious.”
E. “I will need to take my medications for a total of 6 weeks.”
Explanation:
- C. Medication Interactions: The client’s statement about notifying the provider if they start any new medications is crucial because TB treatment involves multiple drugs (Ethambutol, Rifampin, Isoniazid, Pyrazinamide) that can have significant interactions with other medications. Rifampin, in particular, is known for inducing cytochrome P450 enzymes, which can decrease the effectiveness of other drugs. Therefore, awareness of potential interactions is vital for the client’s safety and the efficacy of their TB treatment.
- D. Contagiousness: The statement about no longer being contagious is important. Clients with TB can be contagious until they have been on appropriate therapy for a specific duration (usually 2 weeks) and show clinical improvement. This understanding indicates the client has received education about TB transmission and is aware of their health status, which is essential for public health safety and their own well-being.
- E. Duration of Treatment: The mention of needing to take medications for a total of 6 weeks reflects an understanding of the treatment regimen. The standard TB treatment duration typically lasts for at least 6 months, depending on the drug sensitivity and the patient’s response to therapy. This knowledge helps the client commit to completing their treatment, which is crucial for preventing drug-resistant TB strains.
Incorrect Statements:
- A. Contact Lenses: While Rifampin can cause orange discoloration of body fluids, it does not affect contact lenses specifically.
- B. Repeat Mantoux Test: This is not standard after treatment initiation; follow-up imaging and sputum tests are usually required.
- F. Medication Observation: This is not a requirement for TB medication adherence unless the client has a history of non-compliance.
- G. Alcohol Intake: Alcohol consumption can exacerbate liver toxicity when taking TB medications, particularly Isoniazid and Rifampin, thus it should be avoided.
Overall, the correct understanding of these statements shows that the client is informed about their condition, treatment regimen, and the importance of adherence and communication with their healthcare provider.